Skip to main content
. 2020 Jul 13;20:504. doi: 10.1186/s12879-020-05230-0

Fig. 2.

Fig. 2

Comparison of prevalence of the dominant genotypes (G1P [8], G2P [4], G3P [8], G8P [4] and G9P [8]) at 95% confidence interval (CI) during the pre- (Jan 2010-Jun 2014) and post-(July 2014 – Dec 2018) vaccine introduction periods in Kenya. The predominant genotypes were selected based on their frequency as indicated in Table 3